This article by Robert Whitaker has been written within an America context (but with wider applicability) and has been published by Mad in America. It begins: “The 2013 federal Open Payments legislation, which requires pharmaceutical companies to disclose their direct payments…
Read more
This article by Robert Whitaker has been published by Mad in America. It begins: “Published reports of clinical trials of psychiatric drugs typically include a graphic showing the efficacy of the study drug in reducing symptoms of the disorder compared with…
Read more
This article by Robert Whitaker in the May 2011 edition of Psychology Today is well worth reading, despite it being published over seven years ago. Subtitled “Should reports from the NIMH’s STAR*D trial be retracted?”, it begins: “For some time now,…
Read more